Generic Drug User Fees Reauthorization: A Victory for Public Health

By: Kathleen Uhl, M.D., and Michael Kopcha, Ph.D., R.Ph. We marked an important milestone in the U.S. generic drug program on Oct. 1, 2017 – the start of the first reauthorization of the Generic Drug User Fee Amendments (GDUFA). These … Continue reading →